跳至主要内容
临床试验/NCT04354584
NCT04354584已完成不适用

Early and Late Pulmonary and Systemic Inflammation in Critically Ill, Mechanically Ventilated Patients With Verified COVID-19

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年4月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Lymphocyte populations

研究概览

简要总结

The aim of the present study is to examine the inflammatory response in the pulmonary compartment and blood of critically ill patients admitted to the ICU with COVID-19.

详细描述

The mechanisms of the ARDS-like respiratory failure observed in patients with COVID-19 are currently unknown, but may be related to a distinct local immune response within the lung. In the present study, we will examine the cellular and humoral pulmonary immune response in mechanically ventilated patients admitted to the ICU with COVID-19 by examining immune cell profiles, cytokine patterns, and the complement pathway in bronchoalveolar lavage fluid, and relate it to the concomitant systemic inflammatory response. We will examine the patients on day 1-3 and 7-9 after ICU admission.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18y
  • Mechanical ventilation
  • Verified COVID-19 (throat swab or tracheal aspirate positive for SARS-CoV-2)
  • ARDS according to the Berlin definition

排除标准

  • Untreated malignant tachycardia or bradycardia
  • Suspected or verified intracranial hypertension (ICP > 15 mmHg)
  • Unilateral lung ventilation
  • Severe non-correctable coagulopathy

结局指标

主要结局

Lymphocyte populations

时间窗: Day 7

Cell populations and subpopulations evaluated by 10 colored flow cytometry (B cells, T cells, TCR subsets, Tregs/Th17, dendritic cells, myeloid cells and neutrophils) in bronchoalveolar lavage fluid and blood

White blood cell counts

时间窗: Day 7

Total white blood cells, neutrocytes, lymphocytes, and monocytes in bronchoalveolar lavage fluid and blood

次要结局

  • Cytokines(Day 7)
  • Microorganisms(Up to 12 weeks)
  • Levels of SARS-CoV-2 in the airways(Day 7)
  • Autoantibodies against type I IFNs in the airways(Day 0)
  • Lectin complement pathway(Day 7)
  • Respiratory pathogens(Day 7)
  • Ribosomal RNA in the airways(Day 7)
  • Surfactant in the airways(Day 0)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronni R. Plovsing

MD, PhD

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验